Navigation Links
China Yingxia International, Inc. Retains CCG Elite
Date:4/14/2008

od manufacturers are small to mid sized companies. The Company has a comparative advantage in capital, $37 million as of year ended, December 31, 2007, and scale compared to other health food companies.

China Yingxia enjoys competitive advantages due to its research and development capabilities, manufacturing capacity and sales force which acts as consultants to consumers. The Company's current growth strategy includes acquisitions as well as organic growth.

"China Yingxia is a leading provider of health food products in the PRC. The Company is uniquely positioned to take advantage of the growing Chinese middle-class consumer, who is keen on living a healthier lifestyle," said Crocker Coulson, President of CCG Elite. "With its wide range of products and services that cater to this lucrative market, China Yingxia is well positioned to succeed in this industry."

About CCG Elite

CCG Elite is a global, full-service investor relations firm, headquartered in Los Angeles, CA with offices in New York City, Newport Beach, Calif., Dallas, Texas, Hong Kong, Beijing, Shanghai and Tel Aviv. CCG Elite is uniquely positioned to provide outsourced, high-level investor relations solutions to its clients, combined with an in-depth understanding of Asia's corporate culture and economic environment, to convey their story to funds and broker-dealers located in the U.S. For further information, contact CCG Elite directly, or visit the Company's Web site at http://www.ccgelite.com .

About China Yingxia International, Inc

China Yingxia International, Inc., through its 100%-owned subsidiary, Harbin Yingxia Industrial Group Co., Ltd. ('Yingxia'), is primarily engaged in the development, production and sales of health food products in China. Yingxia is located in the Province of Heilongjiang in mainland China. Yingxia's products include soybean-based foods and drinks, longgu golden millet enriched pr
'/>"/>

SOURCE China Yingxia International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... The U.S. Government, through the U.S. Agency for ... additional $600,000 to help combat the cholera ou...n to the $4 million water, sanitation, and hygiene...n Zimbabwe. , , "Before cholera was widespr... community to prepare for the possibility of an ou...
(Date:12/4/2008)...ard dose of daunorubicin, study shows , ,... of the chemotherapy drug daunorubicin prolonged s...te myeloid leukemia (AML), preliminary results of ...itute (NCI) show. , AML is a cancer of the bloo...s, aged 16 to 60, who were randomly assigned to re...
(Date:12/4/2008)...nt gene could ease sickle-cell disease and thalass..., 2008 -- Researchers at Children,s Hospital Bosto...ncer Institute have identified a way to get red bl... made only before birth or by young infants. This ...d beta-thalassemia -- life-threatening inherited a...
(Date:12/4/2008)...ufacturers A Way to Improve Toy Safety by Meeting ...ty Improvement Act , , ANN ARBOR, Mich., De... continue to generate concerns among consumers abo...g the importance of toy testing. The NSF Toy Safet...at include auditing, testing and assessment. This ...
Breaking Medicine News(10 mins):Health News:USAID Increases Assistance for Zimbabwe Cholera Outbreak 2Health News:Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients 2Health News:Turning back the Clock in Inherited Anemias 2Health News:Turning back the Clock in Inherited Anemias 3Health News:Turning back the Clock in Inherited Anemias 4Health News:NSF International Offers Answers to Rising Toy Safety Concerns 2
...spread neurodegenerative cause of dementia . It sh...kinson's disease. Getting the accurate diagnosis i...used to treat the mental health symptoms of Alzhei...azardous for people with dementia with Lewy bodies...
...cher has shown how the brain hears shapes and how ...lled LOtv that lights up when one identifies an ob...i and his team taught seven sighted volunteers to ... converts visual details into sound, using pitch t...
...e roaming our pastures, reports Cath ODriscoll in ...ientists in New Zealand have discovered that some ...o produce skimmed milk and plan to use this inform...ucing only skimmed milk. The researchers also pla...
...from Asia - including India's - met European Union...on world crises. The two-day Asia-Europe Meeting ...on between European countries seeking deep cuts in...Asian governments countering that they did not cau...
Other Medicine News:Health News:Personality Changes may Help to Identify a Form of Dementia 2Health News:Genes That Produce 'skimmed Milk' in Cows Identified 2Health News:EU Pushes Asian Nations on Climate Change Goals 2
(Date:12/3/2008)...ITE PLAINS, N.Y., Dec. 3 The Leuke...ointly announce the beginning of a new clinical tr... of California, San Diego (UCSD). , , LL... it will speed the development and approval of a n...arabine refractory and/or 17p deleted chronic lymp...
(Date:12/3/2008)...N DIEGO, Dec. 3 Vical In...xclusive, binding letter of intent with EIP,Eczac...eting of the company,s,Allovectin-7(R) immunother...h,Republic of Northern Cyprus. EIP has agreed to ... territory and to pay Vical upfront and milestone ...
(Date:12/2/2008)... JOLLA, Calif., Dec. 2 TorreyPines...ced positive results from a 26 patient Phase II tr...t for xerostomia, or dry mouth, in patients with S...t of a statistically significant increase in saliv...ee doses: 10 mg, 15 mg, and 20 mg. These doses wer...
(Date:12/1/2008)...CKVILLE, Md., Dec. 1 Van...publication in The Lancet , one of the world,s le... of its novel circadian regulator, experimental co...Rajaratnam et al(1) is entitled "Melatonin agonist...r sleep-time shift: two randomised controlled mult...
Breaking Medicine Technology:The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Enlarged Prostate Treatment Study Shows Combination of AVODART 28R 29 and Tamsulosin Provides Greater Benefit Than Either Medication Alone 9750 1Enlarged Prostate Treatment Study Shows Combination of AVODART 28R 29 and Tamsulosin Provides Greater Benefit Than Either Medication Alone 9750 2Enlarged Prostate Treatment Study Shows Combination of AVODART 28R 29 and Tamsulosin Provides Greater Benefit Than Either Medication Alone 9750 3Enlarged Prostate Treatment Study Shows Combination of AVODART 28R 29 and Tamsulosin Provides Greater Benefit Than Either Medication Alone 9750 4Enlarged Prostate Treatment Study Shows Combination of AVODART 28R 29 and Tamsulosin Provides Greater Benefit Than Either Medication Alone 9750 5Parker Waichman Alonso LLP Becnel Law Firm LLC Douglas 26 London P C Levin 9746 1One third of stunting and a quarter of deaths among under 3s in poor countries could be prevented 9744 1One third of stunting and a quarter of deaths among under 3s in poor countries could be prevented 9744 2Former Sufferer of Rare Disease Called Musicogenic Epilepsy Thanks LIJ Medical Team That Ended Her Seizures and Gave Her Back the Gift of Music 9743 1Former Sufferer of Rare Disease Called Musicogenic Epilepsy Thanks LIJ Medical Team That Ended Her Seizures and Gave Her Back the Gift of Music 9743 2
...ssional Offers Patient Tips to Guard Against,Hospi.../PRNewswire/ -- Hospital,infections are among the ...es, according to the Centers for Disease Control. ...into hospitals with,minor conditions and leave und...g the right questions to ask about how hospitals,p...
...Closer to Targeted, Improved Therapies , BETHESDA,...ational Institute on Drug Abuse (NIDA), part of th...t time identified genes that,might increase a pers...ough research was conducted by Dr. George Uhl at N...y Dr. Jed Rose at the,Center for Nicotine and Smok...
Other Medicine Technology:Six Important Things to Know About Preventing Hospital Infections 2Six Important Things to Know About Preventing Hospital Infections 3NIDA Study Identifies Genes That Might Help Some People Abstain,from Smoking 2NIDA Study Identifies Genes That Might Help Some People Abstain,from Smoking 3
FLUORAT®-02-PANORAMA spectrofluorometer is the most sophisticated instrument among the FLUORAT®-02 family. It is intended for scientific research, chromatographic analysis, and for operatio
The Gemini XPS spectrofluorometer allows for fast, high-sensitivity measurements as required by most of today's fluorescence-based assays. Cellular and molecular binding studies, DNA quantitation, dr
The FluoroMax-3 is the entry level spectrofluorometer from Spex®, yet offers features not found in most of the top models of the competition.
The new Gemini EM microplate spectrofluorometer builds on the successful Gemini platform. This next generation reader incorporates all of the high performance features of the Gemini XS with new capab
Medicine Products: